Rothan, H. A., Mohamed, Z., Suhaeb, A. M., Rahman, N. A., & Yusof, R. (2013). Antiviral Cationic Peptides as a Strategy for Innovation in Global Health Therapeutics for Dengue Virus: High Yield Production of the Biologically Active Recombinant Plectasin Peptide. Mary Ann Liebert, Inc.
Citação norma ChicagoRothan, Hussin A., Zulqarnain Mohamed, Abdulrazzaq M. Suhaeb, Noorsaadah Abd Rahman, and Rohana Yusof. Antiviral Cationic Peptides As a Strategy for Innovation in Global Health Therapeutics for Dengue Virus: High Yield Production of the Biologically Active Recombinant Plectasin Peptide. Mary Ann Liebert, Inc, 2013.
Citação norma MLARothan, Hussin A., et al. Antiviral Cationic Peptides As a Strategy for Innovation in Global Health Therapeutics for Dengue Virus: High Yield Production of the Biologically Active Recombinant Plectasin Peptide. Mary Ann Liebert, Inc, 2013.